Thursday, May 24, 2018
engineered enzymes for better healthcare

 

Biotinidase Deficiency (BIO) is caused by the lack of biotinidase enzyme to liberate bound biotin. Without sufficient free biotin several other critical enzyme systems are unable to function properly. It occurs in about 1 in 60,000 newborns and can result in developmental delay, seizures, eczema, hearing loss and death in severe cases. Treatment is simple and involves daily doses of biotin supplement.

Product Info

 

amino-acid-disorders-productEnzyme Deficiency Disorders

GAL      Galactosaemia

G6PD    Glucose-6P Dehydrogenase Deficiency

BIO       Biotinidase Deficiency

 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...